California Stem Cell Treatment Center, Inc. v. United States
Pending petition
Issues: (1) Whether stem cells removed, isolated, and then reimplanted in a patient’s own stem cells to promote natural healing via surgical procedure are “drugs” subject to regulation under the Food Drug and Cosmetic Act; and (2) whether, if so, the Food and Drug Administration had a lawful basis for an enforcement action to prevent prevent physicians from undertaking the procedure given the FDA's own “same surgical procedure” exception to the Act.
| Date | Proceedings and Orders |
|---|---|
| 02/11/2025 | Application (24A784) to extend the time to file a petition for a writ of certiorari from March 20, 2025 to May 19, 2025, submitted to Justice Kagan. |
| 02/14/2025 | Application (24A784) granted by Justice Kagan extending the time to file until May 19, 2025. |
| 05/19/2025 | Petition for a writ of certiorari filed. (Response due June 20, 2025) |
| 06/09/2025 | Waiver of right of respondent United States to respond filed. |
| 06/17/2025 | DISTRIBUTED for Conference of 9/29/2025. |
| 06/18/2025 | Motion for leave to file amicus brief filed by Goldwater Institute. (Distributed) |
| 06/20/2025 | Brief amicus curiae of Association of American Physicians and Surgeons filed. (Distributed) |
| 10/06/2025 | DISTRIBUTED for Conference of 10/10/2025. |